DUBLIN, Ohio, Feb. 17 /PRNewswire-FirstCall/ -- Cardinal Health today announced it has reached agreement with the Food and Drug Administration (FDA) on an amended consent decree regarding the company's infusion pump products. Cardinal Health has...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Cardinal Health, FDA Amend Infusion Pump Consent Decree
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account